Inovio Pharmaceuticals (INO) Revenue (2010 - 2025)
Inovio Pharmaceuticals (INO) posted Revenue of $65,343 for FY2025, down 70.0% from $217,756 in FY2024.
Analysis
Inovio Pharmaceuticals (INO) Revenue (2010 - 2025) Analysis & Trends
Since FY2009, Inovio Pharmaceuticals has reported Revenue for 17 years.
- Annual Revenue has declined for three consecutive years, with a five-year compound annual growth rate of -61.2% (FY2020 to FY2025).
- The FY2025 figure stands as the lowest annual Revenue in data going back to FY2009.
- Business Quant data shows INO's Revenue at $217,756 in FY2024 (-73.8%), $832,010 in FY2023 (-91.9%), $10.26 million in FY2022 (+478.2%) and $1.77 million in FY2021 (-76.1%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Inovio Pharmaceuticals | 99.58 Mn | 99.58 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 65,343.00 |
| Dec 31, 2024 | 116,994.00 |
| Jun 30, 2024 | 100,762.00 |
| Dec 31, 2023 | 102,651.00 |
| Sep 30, 2023 | 388,446.00 |
| Jun 30, 2023 | 225,971.00 |
| Mar 31, 2023 | 114,943.00 |
| Dec 31, 2022 | 124,666.00 |
| Sep 30, 2022 | 9.15 Mn |
| Jun 30, 2022 | 784,395.00 |
| Mar 31, 2022 | 199,074.00 |
| Dec 31, 2021 | 839,115.00 |
| Sep 30, 2021 | 291,698.00 |
| Jun 30, 2021 | 272,824.00 |
| Mar 31, 2021 | 371,120.00 |
| Dec 31, 2020 | 5.58 Mn |
| Sep 30, 2020 | 236,178.00 |
| Jun 30, 2020 | 267,187.00 |
| Mar 31, 2020 | 1.33 Mn |
| Dec 31, 2019 | 279,488.00 |
API Access
Inovio Pharmaceuticals Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=INO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "INO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=INO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();